Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anand V. Kulkarni, Jason Lee & K. Rajender Reddy. (2023) Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI). Expert Review of Gastroenterology & Hepatology 17:11, pages 1067-1079.
Read now
Read now
Mauro Bernardi, Caterina Maggioli, Valmir Dibra & Giacomo Zaccherini. (2012) QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?. Expert Review of Gastroenterology & Hepatology 6:1, pages 57-66.
Read now
Read now
Lars Aabakken. (2008) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:9, pages 1027-1029.
Read now
Read now
Articles from other publishers (15)
Alain Braillon. (2023) Diagnosis and Treatment of Cirrhosis. JAMA 330:10, pages 969.
Crossref
Crossref
Liangqi Chen, Quan Zhang, Hongyi Li & Ke Ma. (2023) Clinical considerations for a gastric Dieulafoy's disease patient: Cardiac arrhythmias caused by SARS‐CoV‐2 or terlipressin?. Journal of Medical Virology 95:5.
Crossref
Crossref
Ewa Szczepanska-Sadowska. (2022) The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases. International Journal of Molecular Sciences 23:22, pages 14414.
Crossref
Crossref
Yeun Tarl Fresner Ng Jao. (2016) Refractory torsade de pointes induced by terlipressin (Glypressin). International Journal of Cardiology 222, pages 135-140.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
366
370
.
G. Sarganas, E. Garbe, A. Klimpel, R. C. Hering, E. Bronder & W. Haverkamp. (2013) Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany. Europace 16:1, pages 101-108.
Crossref
Crossref
S. K. Sidhu & D. Das. (2013)
Terlipressin‐induced
QT
prolongation
. Internal Medicine Journal 43:9, pages 1050-1051.
Crossref
Crossref
Marko Lehmann, Tony Bruns & Andreas Stallmach. (2012)
Risk factors for
QT
interval prolongation owing to acute gastrointestinal haemorrhage in patients with cirrhosis
. Liver International 33:2, pages 321-321.
Crossref
Crossref
Matthias Hinz, Alexander Wree, Christoph Jochum, Lars P. Bechmann, Fuat Saner, Alexander L. Gerbes, Guido Gerken & A.l.i. Canbay. (2013) High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome. Annals of Hepatology 12:1, pages 92-99.
Crossref
Crossref
M. Lehmann, T. Bruns, A. Herrmann, M. Fritzenwanger & A. Stallmach. (2010) 54-jähriger Patient mit Leberzirrhose und therapiebedingten Torsade-de-pointes-Tachykardien54-year-old male with hepatic cirrhosis and therapy-associated torsade de pointes tachycardia. Der Internist 52:4, pages 445-450.
Crossref
Crossref
R.C.L. Page. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
909
919
.
Abdul-Naser Elzouki, Ayman El-Menyar, Emad Ahmed, Mohammed E. Elbadri, Yahia Z. Imam & Bahlul A. Gurbanna. (2010) Terlipressin-induced severe left and right ventricular dysfunction in patient presented with upper gastrointestinal bleeding: case report and literature review. The American Journal of Emergency Medicine 28:4, pages 540.e1-540.e6.
Crossref
Crossref
James A Russell. (2009) Bench-to-bedside review: Vasopressin in the management of septic shock. Critical Care 15:4, pages 226.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:1.
Crossref
Crossref
Aleksander Krag, Tine Borup, Søren Møller & Flemming Bendtsen. (2008) Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Advances in Therapy 25:11, pages 1105-1140.
Crossref
Crossref